Drug intelligence / Profile preview

sennoside a

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Sennoside A is a natural **dianthrone glycoside** derived mainly from medicinal plants such as Senna and Rhubarb. It is the principal active constituent of several traditional herbal remedies and is chiefly recognized as an **irritant laxative**. Sennoside A acts principally by stimulating colonic motility through direct irritation of the intestinal mucosa, which results in increased peristalsis and bowel evacuation. Beyond its established use for constipation, sennoside A exhibits diverse pharmacological actions including **anti-obesity, hypoglycemic, hepatoprotective, anti-inflammatory, anti-fibrotic, anti-tumor, antibacterial, antifungal, antiviral, and anti-neurodegenerative effects**. Its molecular formula is C42H38O20 with a molecular weight of 862.7 and low water solubility. Sennoside A is also incorporated as an active ingredient in various health supplements and weight-loss products, predominantly in Asia. Long-term or high-dose use has been associated with risks such as melanosis coli and possible carcinogenesis. Sennoside A has poor bioavailability and is metabolized by gut microbiota, which transform it to active aglycone derivatives exerting the laxative effect[1][6][4][10].

Brand names
PursenniGlysennidPursennidGlysennideSennosidePursennideSennoside A1
Other names
SennosidaSennoside ASennoside A1
02

Targets

DNMT1 (DNA (cytosine-5)-methyltransferase 1)ATP4A (Potassium–transporting ATPase alpha chain 1)

Beyond the preview

Go deeper on sennoside a.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sennoside a.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call